☰

Botond Timar, Ph.D. - Publications

Affiliations: 
2006 Semmelweis Egyetem, Hungary 
Area:
Oncology
Tree Info Grants Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Nagy Á, Bátai B, Kiss L, Gróf S, Király PA, Jóna Á, Demeter J, Sánta H, Bátai Á, Pettendi P, Szendrei T, Plander M, Körösmezey G, Alizadeh H, Kajtár B, et al. Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma. Journal of Internal Medicine. PMID 37259686 DOI: 10.1111/joim.13674  0.58
2023 Krizsán S, Péterffy B, Egyed B, Nagy T, Sebestyén E, Hegyi LL, Jakab Z, Erdélyi DJ, Müller J, Péter G, Csanádi K, Kállay K, Kriván G, Barna G, Bedics G, et al. NEXT-GENERATION SEQUENCING-BASED GENOMIC PROFILING OF CHILDREN WITH ACUTE MYELOID LEUKEMIA. The Journal of Molecular Diagnostics : Jmd. PMID 37088137 DOI: 10.1016/j.jmoldx.2023.04.004  0.628
2022 Nagy ZF, Ferenczi K, Istenes I, Eid H, Bödör C, Timár B, Demeter J. Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia. Pathology Oncology Research : Por. 28: 1610338. PMID 35570843 DOI: 10.3389/pore.2022.1610338  0.398
2021 Gángó A, Kiss R, Farkas P, Hanna E, Demeter J, Deák B, Lévai D, Kotmayer L, Alpár D, Matolcsy A, Bödör C, Mátrai Z, Timár B. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax. Pathology. PMID 34332791 DOI: 10.1016/j.pathol.2021.04.008  0.612
2021 Czeti Á, Szalóki G, Varga G, Szita VR, Komlósi ZI, Takács F, Márk Á, Timár B, Matolcsy A, Barna G. Limitations of VS38c labeling in the detection of plasma cell myeloma by flow cytometry. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 34296508 DOI: 10.1002/cyto.a.24488  0.556
2020 Csernus B, Timár B, Fülöp Z, Matolcsy A. Grade I, II and III Follicular Lymphomas Express Ig V Genes with Different Patterns of Somatic Mutation. Pathology Oncology Research : Por. PMID 32705429 DOI: 10.1007/S12253-020-00843-X  0.756
2020 Omidvar N, Tekin N, Conget P, Bruna F, Timar B, Gagyi E, Basak R, Auewarakul C, Sritana N, Cerci JJ, Dimamay MP, Gyorke T, Redondo F, Nair R, Gorospe C, et al. Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring System. Acta Haematologica. 1-3. PMID 32187599 DOI: 10.1159/000505605  0.768
2020 Saft L, Timar B, Porwit A. Enumeration of CD34+ blasts by immunohistochemistry in bone marrow biopsies from MDS patients may have significant impact on final WHO classification Journal of Hematopathology. 13: 79-88. DOI: 10.1007/S12308-020-00394-9  0.314
2018 Mózes R, Gángó A, Sulák A, Vida L, Reiniger L, Timár B, Krenács T, Alizadeh H, Masszi T, Gaál-Weisinger J, Demeter J, Csomor J, Matolcsy A, Kajtár B, Bödör C. Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms. Pathology. PMID 30606612 DOI: 10.1016/J.Pathol.2018.11.007  0.597
2018 Gángó A, Mózes R, Boha Z, Kajtár B, Timár B, Király PA, Kiss R, Fésüs V, Nagy N, Demeter J, Körösmezey G, Borbényi Z, Marton I, Szőke A, Masszi T, et al. Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms. Leukemia Research. 65: 42-48. PMID 29306106 DOI: 10.1016/J.Leukres.2017.12.005  0.611
2017 Timár B. [The pathology and genetic background of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia]. Magyar Onkologia. 61: 6-11. PMID 28273183  0.368
2016 Tekin N, Omidvar N, Morris TP, Conget P, Bruna F, Timar B, Gagyi E, Basak R, Naik O, Auewarakul C, Sritana N, Levy D, Cerci JJ, Bydlowski SP, Pereira J, et al. Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score. Oncotarget. PMID 27825111 DOI: 10.18632/Oncotarget.13066  0.773
2016 Márk Á, Varga G, Timár B, Kriston C, Szabó O, Deák L, Matolcsy A, Barna G. The effect of microenvironmental factors on the development of myeloma cells. Hematological Oncology. PMID 27766647 DOI: 10.1002/Hon.2354  0.6
2016 Carr R, Ozdag H, Tekin N, Morris T, Conget P, Bruna F, Timar B, Gagyi E, Basak R, Naik O, Auewarakul C, Srithana N, Dimamay MP, Natividad F, Chung JK, et al. The effect of biological heterogeneity on R-CHOP treatment outcome in diffuse large B-cell lymphoma across five international regions. Leukemia & Lymphoma. 1-6. PMID 27724056 DOI: 10.1080/10428194.2016.1231308  0.754
2015 Sebestyén A, Nagy N, Márk Á, Molnár A, Dankó T, Hajdu M, Tóth M, Timár B, Csóka M, Kopper L. Abstract B47: mTOR C1/2 activities - related protein expression and its potential prognostic/therapeutic importance in certain lymphoid malignancies Molecular Cancer Therapeutics. 14. DOI: 10.1158/1538-8514.Pi3K14-B47  0.439
2013 Boi M, Rinaldi A, Kwee I, Bonetti P, Todaro M, Tabbò F, Piva R, Rancoita PM, Matolcsy A, Timar B, Tousseyn T, Rodríguez-Pinilla SM, Piris MA, Beà S, Campo E, et al. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood. 122: 2683-93. PMID 24004669 DOI: 10.1182/Blood-2013-04-497933  0.689
2013 Matrai Z, Andrikovics H, Csomor J, Timár B, Kozma A, Tordai A, Masszi T. Extramedullary Myeloid Sarcoma With Eosinophilia and FIP1L1-Pdgfra Rearrangement: Complete Cytogenetic Response To Imatinib Therapy Blood. 122: 5033-5033. DOI: 10.1182/Blood.V122.21.5033.5033  0.408
2012 Sebestyén A, Sticz TB, Márk A, Hajdu M, Timár B, Nemes K, Nagy N, Váradi Z, Kopper L. Activity and complexes of mTOR in diffuse large B-cell lymphomas--a tissue microarray study. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 25: 1623-8. PMID 22899290 DOI: 10.1038/Modpathol.2012.141  0.496
2011 Barna G, Mihalik R, Timár B, Tömböl J, Csende Z, Sebestyén A, Bödör C, Csernus B, Reiniger L, Peták I, Matolcsy A. ROR1 expression is not a unique marker of CLL. Hematological Oncology. 29: 17-21. PMID 20597086 DOI: 10.1002/Hon.948  0.677
2011 Sticz TB, Mark A, Hajdu M, Timar B, Nemes K, Kopper L, Sebestyen A. Abstract 3163: Tissue-micro array based IHC analysis of mTOR activity in DLBCL Cancer Research. 71: 3163-3163. DOI: 10.1158/1538-7445.Am2011-3163  0.425
2010 Szepesi Á, Erõs N, Tímár B, Horváth B, Matolcsy A, Csomor J. 32 Intravascular large B-cell lymphoma: clinicopathological study of seven cases European Journal of Cancer Supplements. 8: 19. DOI: 10.1016/S1359-6349(10)70703-5  0.648
2008 Gagyi E, Balogh Z, Bödör C, Timár B, Reiniger L, Deák L, Csomor J, Csernus B, Szepesi A, Matolcsy A. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression. Haematologica. 93: 1822-8. PMID 18945749 DOI: 10.3324/Haematol.13239  0.705
2008 Csomor J, Kaszás I, Kollár B, Pajor L, Egyházi Z, Fekete S, Egyed M, Timár B. Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma. Pathology Oncology Research : Por. 14: 281-4. PMID 18493873 DOI: 10.1007/S12253-008-9051-Y  0.414
2007 Csomor J, Fónyad L, Reiniger L, Timár B. P132 Intravascular large B-cell lymphoma Blood Reviews. 21: S128. DOI: 10.1016/S0268-960X(07)70210-2  0.337
2006 Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation]. Orvosi Hetilap. 147: 2175-9. PMID 17402211  0.569
2004 Csernus B, Timár B, Fülöp Z, Bognár A, Szepesi A, László T, Jáksó P, Warnke R, Kopper L, Matolcsy A. Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cells origin of mediastinal (thymic) B-cell lymphoma. Leukemia & Lymphoma. 45: 2105-10. PMID 15370257 DOI: 10.1080/1042819042000219467  0.761
2004 Timár B, Fülöp Z, Csernus B, Angster C, Bognár A, Szepesi A, Kopper L, Matolcsy A. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome. Leukemia. 18: 326-30. PMID 14671632 DOI: 10.1038/Sj.Leu.2403249  0.701
2004 Timar B, Chadburn A, Knowles D, Cesarman E. Activation of Classical and Alternative Nuclear Factor-kappaB (NF-kB) Pathways in Diffuse Large B-Cell Lymphomas. Blood. 104: 29-29. DOI: 10.1182/Blood.V104.11.29.29  0.359
2003 Fülöp Z, Csernus B, Tímár B, Szepesi A, Matolcsy A. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Leukemia. 17: 411-5. PMID 12592341 DOI: 10.1038/Sj.Leu.2402792  0.647
2000 Nagy M, Balázs M, Adám Z, Petkó Z, Tímár B, Szereday Z, László T, Warnke RA, Matolcsy A. Genetic instability is associated with histological transformation of follicle center lymphoma. Leukemia. 14: 2142-8. PMID 11187904 DOI: 10.1038/Sj.Leu.2401978  0.657
Show low-probability matches.